Schizophrenia

European Parliament Interest Group on Mental Health, Well-being and Brain Disorders

Tuesday 5th November, 12:30 – 14.30

Effectively addressing schizophrenia in policy, diagnosis and treatment

AGENDA

Welcome and introductions:  Jean Lambert MEP

Part 1:

GAMIAN-Europe survey on adherence to treatment amongst 400 patients with schizophrenia
Paul Arteel, GAMIAN-Europe
IG 20131105 presentation Arteel Adherence

Panel response:
Mark Hermans, Child and Adolescent Psychiatrist, Belgium
Rebecca Muller, GAMIAN-Europe

Part 2:

‘Schizophrenia: Time to Commit to Policy Change’
Silvana Galderisi, Second University of Naples, Italy
IG 20131105 presentation Galderisi

Panel response:
Jelmer Abrahams, Anoiksis (NL)
Mary Baker, European Brain Council
Jürgen Scheftlein, European Commission, DG SANCO

Conclusions and close
Nessa Childers MEP
Jean Lambert MEP

Full report

documents presented:
Gamian survey results: Gamian Europe Adherence report 2012
Oxfordgenesis report: Schizophrenia Policy Change_Oct 2013

 

Follow up:

PQ: IG 20131105 PQ

Answer: IG 20131105 Answer

 

 

 

 

LEARN MORE ON THIS TOPIC

Related Blog Posts

Unmet Needs and Opportunities of Psychopharmacology in Chidren & Adolescents: The Lancet Psychiatry Position Paper is out!

by | Dec 8, 2023 |

The Lancet Psychiatry Journal published on 7 December, 2023 its position paper “Psychopharmacology in Chilrden and Adolescents : Unmet needs and opportunities”. It focuses on psychopharmacology in children and adolescents, discussing the unmet needs and opportunities in this area, highlighting current challenges and potential advancements in treating mental health conditions.